SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the launch of updated t:slim X2™ insulin pump ...
Abbott’s latest innovation, the FreeStyle Libre® 2 Plus sensor, is available for the first time for t:slim X2™ insulin pump users in the U.S. Tandem’s Control-IQ™ hybrid closed-loop technology now ...
The t:slim X2 system (left) and FreeStyle Libre 3 (right). [Images courtesy of Tandem Diabetes Care and Abbott] On social media, Tandem Diabetes Care (Nasdaq:TNDM) said the launch of a new integration ...
Tandem Diabetes has announced that the t:slim X2 insulin pump, featuring Control-IQ+ automated insulin delivery (AID) technology, is now available with Abbott’s FreeStyle Libre 3 Plus ...
The t:slim X2 Pump is also the only insulin pump capable of remote software updates 2, allowing existing users to add features like CGM integration from home. It is up to 38% smaller than other pumps ...